Specific sialylation of N-glycans and its novel regulatory mechanism
Glycoconjugate Journal · 2024-06 · 41 (3) · 175-183
DOI: 10.1007/s10719-024-10157-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Glycoconjugate Journal, online erschienen am 03.07.2024. Verfasst von Jianguo Gu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Regulatory Glycobiology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsu…. Hauptthemen laut MEDLINE: Sialyltransferases, Polysaccharides. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tohoku Medical and Pharmaceutical University.
Abstract (Originalsprache)
Altered glycosylation is a common feature of cancer cells. Some subsets of glycans are found to be frequently enriched on the tumor cell surface and implicated in different tumor phenotypes. Among these, changes in sialylation have long been associated with metastatic cell behaviors such as invasion and enhanced cell survival. Sialylation typically exists in three prominent linkages: α2,3, α2,6, and α2,8, catalyzed by a group of sialyltransferases. The aberrant expression of all three linkages has been related to cancer progression. The increased α2,6 sialylation on N-glycans catalyzed by β-galactoside α2,6 sialyltransferase 1 (ST6Gal1) is frequently observed in many cancers. In contrast, functions of α2,3 sialylation on N-glycans catalyzed by at least three β-galactoside α2,3-sialyltransferases, ST3Gal3, ST3Gal4, and ST3Gal6 remain elusive due to a possibility of compensating for one another. In this minireview, we briefly describe functions of sialylation and recent findings that different α2,3 sialyltransferases specifically modify target proteins, as well as sialylation regulatory mechanisms vis a complex formation among integrin α3β1, Golgi phosphoprotein 3 (GOLPH3), phosphatidylinositol 4-kinase IIα (PI4KIIα), focal adhesion kinase (FAK) and sialyltransferase, which suggests a new concept for the regulation of glycosylation in cell biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Regulatory Glycobiology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai, Miyagi, 981-8558, Japan. jgu@tohoku-mpu.ac.jp.
- Division of Regulatory Glycobiology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai, Miyagi, 981-8558, Japan.
Förderung
- Tohoku Medical and Pharmaceutical University
Zitieren
APA
Gu, J., & Isaji, T. (2024). Specific sialylation of N-glycans and its novel regulatory mechanism. Glycoconjugate Journal, 41(3), 175-183. https://doi.org/10.1007/s10719-024-10157-8
Vancouver
Gu J, Isaji T. Specific sialylation of N-glycans and its novel regulatory mechanism. Glycoconjugate Journal. 2024;41(3):175-183. doi:10.1007/s10719-024-10157-8
BibTeX
@article{Gu2024,
author = {Gu, Jianguo and Isaji, Tomoya},
title = {Specific sialylation of N-glycans and its novel regulatory mechanism},
journal = {Glycoconjugate Journal},
year = {2024},
volume = {41},
number = {3},
pages = {175--183},
doi = {10.1007/s10719-024-10157-8}
}
EUVIMED